Spot gold rises to a record high, quoted at 2740.7 US dollars per ounce

Takeda Pharmaceutical and Protagonist Therapeutics Inc (NASDAQ: PTGX) jointly announced that the U.S. Food and Drug Administration (FDA) has officially accepted the New Drug Application (NDA) for their co-developed drug Rusfertide and granted it priority review status.

Rising LNG demand offsets oversupply concerns, Excelerate Energy (EE.US) receives target price upgrades from both Morgan Stanley and Deutsche Bank

Hong Kong-based crypto custody firm UDynamics (UDUD.US) applies for U.S. IPO, aiming to raise $18 million

Earnings Preview | After the "performance slump" in cybersecurity stocks, can CrowdStrike (CRWD.US) stand out on its own in Q4?